Fibrin matrices in tissue engineering

Natural-Based Polymers for Biomedical Applications

Volumn , Issue , 2008, Pages 533-548

  Tawil, B ^a   Duong, H ^a   Wu, B ^a  

^a University of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN MATRIX;

TISSUE ENGINEERING;

EID: 84902706382     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1533/9781845694814.4.533     Document Type: Chapter

References (92)

1. Albes J.M., Klenzner T., Kotzerke J., Thiedemann K.U., Schafers H.-J., Borst H.-G. Improvement of tracheal autograft revascularization by means of fibroblast growth factor. Ann Thorac Surg 1994, 57:444.
2. Amrani D. Wound healing: role of commercial fibrin sealants. Annals of the New York Academy of Sciences 2001, 936:566.
3. Andree C., Voigt M., Wenger A., Erichsen T., Bittner K., Schaefer D., Walgenbach K.J., Borges J., Horch R.E., Eriksson E., Stark G.B. Plasmid gene delivery to human keratinocytes through a fibrin-mediated transfection system. Tissue Engineering 2001, 7:757.
4. Ariens R.A., Lai T.-S., Weisel J.W., Greenberg C.S., Grant P.J. Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood 2002, 100(3):743.
5. Boyles P.W., Ferguson J.H., Muehlke P.H. Mechanism involved in fibrin formation. Journal of General Physiology 1950, 492-513.
6. Budzynski A.Z., Olexa S.A. Localization of a fibrin polymerization site. Journal of Biological Chemistry 1981, 256(7):3544-3549.
7. Busuttil R.W. A comparison of antifibrinolytic agents used in hemostatic fibrin sealants. J Am Coll Surg 2003, 1021-1028.
8. Catelas I., Sese N., Wu B., Dunn J., Helgerson S., Tawil B. Human mesenchymal stem cells proliferation and osteogenic differentiation in fibrin gels in vitro. Tissue Engineering 2006, 12(8):1-9.
9. Christman K.L., Fok H.H., Sievers R.E., Fang O., Lee R.J. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Engineering 2004, 10(3-4):403-409.
10. Christman K.L., Vardanian A.J., Fang O., Sievers R.E., Fok H.H., Lee R.J. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol 2004, 44:654-660. doi:10.1016/j.jacc.2004.04.040.
11. Clark R.A.F. The Molecular and Cellular Biology of Wound Repair 1998, Plenum Press, New York.
12. Codispoti M., Mankad P.S. Significant merits of a fibrin sealant in the presence of coagulopathy following paediatric cardiac surgery: randomized controlled trial. Eur J Cardiothorac Surg 2002, 22:200-205.
13. R as a delivery vehicle for active macrophage activator LipoProtein - 2 Peptide: in vitro studies. Wound Repair and Regeneration 2007, 15(4):521-529.
14. Cox S., Cole M., Tawil N. The behavior of human dermal fibroblasts in 3 dimensional fibrin clots: dependence on the fibrinogen and thrombin concentration. Tissue Engineering 2004, 10(5/6):942.
15. Daculsi G., Goyenvalle E., Aguado E., Bilban M., Bittner K., Gobin C., Spaethe R. Osteopromoting properties of new injectable fibrin-bioceramic composite for bone regeneration 2004, 8th World Biomaterials Congress, Sydney, Australia.
16. Demaat M.P.M., Laurens N., Koolwijk P. Fibrin structure and wound healing. Journal of Thrombosis and Haemostasis 2006, 4(5):932-939.
17. Despotis G.J., Joist H., Joiner Maier D., Alsoufiev A.L., Triantafillou A.N., Goodenough L.T., Santoro S.A., Happas D.G. Effect of aprotinin on activated clotting time whole blood and plasma heparin measurements. Ann Thorac Surg 1995, 59:106-111.
18. Diegelmann R.F., Evans M.C. Wound healing: an overview of acute, fibrotic and delayed healing. Frontiers in Bioscience 2004, 9:283-289.
19. Dragieva G., Jen A., Bavand M., Hubbell J.A., Fetz D., Burg G., Hafner J. 2004.
20. Drew A.F., Liu H., Davidson J.M., Daugherty C.C., Degen J.L. Wound-healing defects in mice lacking fibrinogen. Blood 2001, 97:3691-3698.
21. Dvorak H.F., Harvey V.S., Estrella P., Brown L.F., Mcdonagh J., Dvorak A.M. Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Vox Sang 1987, 57:673-686.
22. Eberhardt R.T., Coffman J.D. Cardiovascular morbidity and mortality in peripheral arterial disease current drug targets. Cardiovascular &Hematological Disorders 2004, 4(3):209-217.
23. Falanga V., Satori I., Chartier M., Yufit T., Butmarc J., Kouttab N., Shrayer D., Carson P. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Engineering 2007, 13(6):1299-1312.
24. Ferguson R., Cox S., Sese N., Cole M., Tawil B. The use of fibrin sealant to deliver neuronal stem cell: In Vitro studies, Society for Biomaterials 2003, Reno, Nevada.
25. Fuerst A., Derungs S., Von Rechenberg B., Auer J.A., Schense J., Watson J. Use of a parathyroid hormone peptide (PTH(1-34))-enriched fibrin hydrogel for the treatment of a subchondral cystic lesion in the proximal interphalangeal joint of a warmblood filly. J Vet Med A Physiol Pathol Clin Med 2007, 54(2):107-112.
26. Furuta A., Shunichiro Miyoshi, Yuji Itabashi, Tatsuya Shimizu, Shinichiro Kira, Keiko Hayakawa, Nobuhiro Nishiyama, Kojiro Tanimoto, Yoko Hagiwara, Toshiaki Satoh, Keiichi Fukuda, Teruo Okano, Satoshi Ogawa Pulsatile cardiac tissue grafts using a novel three-dimensional cell sheet manipulation technique functionally integrates with the host heart, in vivo. Circ Res 2006, 98:705-712.
27. Giovannacci L., Eugster T., Stierli P., Hess P., Gurke L. Does fibrin glue reduce complications after femoral artery surgery? A randomised trial. Eur J Vasc Endovasc Surg 2002, 24(3):196-201.
28. Hall C.E., Slayter H.S. The fibrinogen molecule: Its size, shape and mode of polymerization. Journal of Biophysical and Biochemical Cytology 1958, 5:11-16.
29. Hanson A.J., Quinn M.T. Effect of fibrin sealant composition on human neutrophil chemotaxis. J Biomed Mater Res 2002, 61:474-481.
30. Hasimoto J., Kurosaka M., Yoshiya S., Hirohata K. Meniscal repair using fibrin sealant and endothelial cell growth factor. Am J Sports Med 1992, 20:537.
31. Henning C., Lynch M.A., Yearout K.M., Vequist S.W., Stallbaumer R.J., Decker K.A. Arthroscopic meniscal repair using an exogenous fibrin clot. Clinical Orthopaedics &Related Research 1990, 252:64-72.
32. Ho W., Tawil B., Dunn J.C.Y., Wu B.M. The behavior of human mesenchymal stem cells in 3d fibrin clots: dependence on fibrinogen concentration and clot structure. Tissue Engineering 2006, 12(6):1-9.
33. Horch R.E., Bannasch H., Stark G.B. Transplantation of cultured autologous keratinocytes in fibrin sealant biomatrix to resurface chronic wounds. Transplant Proc 2001, 33(1-2):642.
34. Horowitz B.H., Varadi A., Scheraga H.A. Localization of a fibrin #-chain polymerization site within segment thr-374 to glu-396 of human fibrinogen. Proceedings of the National Academy of Sciences USA 1984, 81(19):5980-5984.
35. Huang Q., Goh J.C.H., Hutmacher D.W., Eng E.H., Lee M.D. In vivo mesenchymal cell recruitment by a scaffold loaded with transforming growth factor β1 and the potential for in situ chondrogenesis. Tissue Engineering 2002, 8(3):469-482.
36. Jockenhoevel S., Zund G., Hoerstrup S.P., Chalabi K., Sachweh J.S., Demircan L., Messner B.J., Turina M. Fibrin gel advantages of a new scaffold in cardiovascular tissue engineering. European Journal of Cardio-thoracic Surgery 2001, 19:424-430.
37. Kemp P. History of regenerative medicine: looking backwards to move forwards. Regenerative Med 2006, 1(5):653-669.
38. Khare A., Woo L., Mclean A., Helgerson S. Mechanical characterization of fibrin gels. Blood Coag Fibrinolysis 1998, 9(7):105.
39. Kirilak Y., Pavlos N.J., Willers C.R., Han R., Feng H., Xu J., Asokananthan N., Stewart G.A., Henry P., Wood D., Zheng M. Fibrin sealant promotes migration and proliferation of human articular chondrocytes: Possible involvement of thrombin and protease-activated receptors. International Journal of Molecular Medicine 2006, 17:551-558.
40. Kjaergard H.K., Weis-Fogh U.S. Important factors influencing the strength of autologous fibrin glue: the fibrin concentration and reaction time-comparison of strength with commercial fibrin glue. Eur Surg Res 1994, 86:481-485.
41. Kneser U., Voogd A., Ohnolz J., Buettner O., Stangenberg L., Zhang Y.H., Stark G.B., Schaefer D.J. Fibrin gel-immobilized primary osteoblasts in calcium phosphate bone cement: in vivo evaluation with regard to application as injectable biological bone substitute. Cells Tissues Organs 2005, 179:158-169.
42. Kostourou V., Robinson S.P., Cartwright J.E., Whitley G.S. Dimethylarginine dimethylaminohydrolase I enhances tumour growth and angiogenesis. British Journal of Cancer 2002, 87:673-680.
43. Lafleur M.A., Handsley M.M., Knauper V., Murphy G., Edwards D.R. Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type matrix metalloproteinases (MT-MMPs). Journal of Cell Science 2002, 115:3427-3438.
44. Lambert C.A., Colige A.C., Munaut C., Lapiere C.M., Nusgens B.V. Distinct pathways in the over-expression of matrix metallopreoteinases in human fibroblasts by relaxation of mechanical tension. Matrix BioI 2001, 20:397.
45. Macphee M.J., Singh M.P., Brady R., Akhyani N., Liau G., Lasa C., Hue C., Best A., Drohan W. Surgical Adhesives and Sealants Current Technology and Applications. Fibrin sealant: a versatile delivery vehicle for drugs and biologics 1996, Technomic Publishing Co., Lancaster, PA. D.H. Sierra, R. Saltz (Eds.).
46. Mah-Becherel M., Ceraline J., Deplanque G., Bergerat J.P., Cazenave J.P., Klein-Soyer C. Anti-angiogenic effects of the thienopyridine SR 25989 in vitro and in vivo in murine pulmonary metastasis model. British Journal of Cancer 2002, 86:803-810.
47. Mana M., Cole M., Cox S., Tawil B. Human U937 monocyte behavior and protein expression on various formulations of three-dimensional fibrin clots. Wound Repair and Regeneration 2006, 14(1):72-80.
48. Marchac D., Greensmith A.L. Early postoperative efficacy of fibrin glue in face lifts: a prospective randomized trial. Plast Reconstr Surg Mar 2005, 115(3):911-916.
49. Marticorena J., Rodriguez-Ares M.T., Tourino R., Mera P., Valladares M.J., Martinez-De-La-Casa J.M., Benitez-Del-Castillo J.M. Pterygium surgery: conjunctival autograft using a fibrin adhesive. Cornea 2006, 25(1):34-36.
50. Massone P.P.B., Magnani B., Conti B., Lequaglie C., Cataldo I. Cauterization versus fibrin glue for aerostasis in precision resections for secondary lung tumors. Annals of Surgical Oncology 2003, 10:441-446.
51. Matarasso A., Rizk S.S., Markowitz J. Short scar face-lift with the use of fibrin sealant. Dermatol Clin 2005, 23(3):495-504. vii.
52. Meana A., Iglesia J., Del Rio M., Larcher F., Madrigal B., Fresno M.F., Martin C., San Roman S., Tevar F. Large surface of cultured human epithelium obtained on a dermal matrix based on live fibroblast-containing fibrin gels. Burns 1998, 24:621-630.
53. Mesa J.M., Zaporojan V., Weinand C., Johnson T.S., Bonassar L., Randolph M.A., Yaremchuk M.J., Butler P.E. Tissue Engineering Cartilage with Aged Articular Chondrocytes In Vivo. Plastic &Reconstructive Surgery 2006, 118(1):41-49.
54. Miller A.G., Bottoms S., Laurent G., Carmeliet P., Herrick S. Fibrin-induced skin fibrosis in mice deficient in tissue plasminogen activator. American Journal of Pathology 2005, 167(3):721-732.
55. Mogford J., Tawil B., Mustoe T. Fibrin sealant combined with fibroblasts and PDGF enhance wound healing in excisional wounds. Wound Repair and Regeneration 2004, 12(2). A9-A9(1).
56. Mosesson M.W., Siebenlist K.R., Meh D.A. The structure and biological features of fibrinogen and fibrin. Ann N Y Acad Sci 2001, 936:11.
57. Nicosia R.F., Tchao R., Leighton J. Angiogenesis-dependent tumor spread in reinforced fibrin clot culture. Cancer Research 1983, 43:2159-2166.
58. Nihouannen D., Saffarzadeh A., Aguado E., Goyenvalle E., Gauthier O., Moreau F., Pilet P., Spaethe R., Daculsi G., Layrolle P. Osteogenic properties of calcium phosphate ceramics and fibrin glue based composites. J of Materials Science 2007, 18(2):225-235.
59. Park S.H., Park S.R., Chung S., Pai K.S., Min B.H. Tissue-engineered cartilage using fibrin/hyaloran composite gel and its in vivo implantation. Artificial Organ 2004, 29(10):838-860.
60. Perez R.L., Roman J. Fibrin enhances the expression of IL-1 beta by human peripheral blood mononuclear cells, Implications in pulmonary inflammation. J Immunol 1995, 154:1879-1887.
61. Perka C., Arnold U., Spitzer R.S., Lindenhayn K. The use of fibrin beads for tissue engineering and subsequential transplantation. Tissue Eng 2001, 7(3):359-361.
62. Radosevich M., Goubran H.A., Burnouf T. Fibrin sealant: scientific rationale, production methods, properties, and current clinical use. Vox Sang 1997, 72:133-143.
63. Roberts W.W., Lorand L., Mockros L.F. Viscoelastic properties of fibrin clots. Biorheology 1973, 10:29.
64. Sade B., Mohr G., Frenkiel S. Management of intra-operative cerebrospinal fluid leak in transnasal transsphenoidal pituitary microsurgery: use of post-operative lumbar drain and sellar reconstruction without fat packing. Acta Neurochir (Wien) 2006, 148(1):13-18. discussion 18-19.
65. Saed G.M., Kruger M., Diamond M.P. Expression of transforming growth factorβ and extracellular matrix by human peritoneal mesothelial cells and by fibroblasts from normal peritoneum and adhesions: Effect of Tisseel. Wound Repair and Regeneration 2004, 12(5):557-564.
66. Sahni A., Francis C.W. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood 2004, 96:3772-3778.
67. Salvino C.K., Esposito T.J., Smith D.K., Jacobs H.K., Candel A.G., Dries D., Gamelli P. Laparoscopic injection of fibrin glue to arrest intraparenchymal abdominal hemorrhage: An experimental study. J Trauma 1993, 35:762-766.
68. Scheberich A., Beretz A. Culture of vascular cells in tri-dimensional (3d) collagen: a methodological review. Therapie 2000, 55(1):35-41.
69. Schense J.C., Bloch J., Aebischer P., Hubbell J.A. Enzymatic incorporation of bioactive peptides into fibrin matrices enhances neurite extension. Nature Biotechnology 2000, 18:415-419.
70. Sese N., Cole M., Cox S., Tawil B. Delivering human keratinocytes using fibrin sealant: in vitro studies 2003, Seattle, Washington.
71. Sese N., Cole M., Tawil B. Cross-talk between fibroblasts and keratinocytes in 3-D fibrin clots, in vitro Studies 2004.
72. Sierra D.H. Fibrin sealant adhesive systems: A review of their chemistry, material properties, and clinical applications. J Biomater Appl 1993, 7:309.
73. Silecchi G., Boru C., Moulel J., Rossi M., Anselmino M., Tacchino R., Foco M., Gaspari A., Gentileschi P., Morino M., Toppino M., Basso N. Clinical evaluation of fibrin glue in the prevention of anastomotic leak and internal hernia after laparoscopic gastric by pass: Preliminary results of a prospective, randomized multicenter trial. Obesity Surgery 2006, 16(2):125-131.
74. Silverman Ronald P., Passaretti David Huang, Wynne Randolph, Mark A., Michae Michael J. Injectable Tissue-Engineered Cartilage Using a Fibrin Glue Polymer. Plastic &Reconstructive Surgery 1999, 103(7):1809-1818.
75. Simon D.I., Ezratty A.M., Francis S.A., Rennke H., Loscalzo J. Fibrin(ogen) is internalized and degraded by activated human monocytoid cells via Mac-1 (CD11b/CD18): a nonplasmin fibrinolytic pathway. Blood 1993, 82:2414-2422.
76. Sohn D., Lottman L., Lum L., Kim S., Pedowitz R., Coutts R., Sah R.L. Effect of Gravity on Localization of Chondrocytes Implanted in Cartilage Defects. Clinical Orthopaedics &Related Research 2002, 394:254-262.
77. Sweeny S.M., Guy C.A., Fields G.B., San Antonio J.D. Defining the domains of type I collagen involved in heparin binding and endothelial tube formation. Pro Natl Acad Sci USA 1998, 95:7275-7280.
78. Sweeny S.M., Dilullo G., Slater S.J., Martinez J., Lozzo R.V., Lauer-Fields J.L., Fields G.B., San Antonio J.D. Angiogenesis in collagen I requires alpha2-beta1 ligation of a GFP*GER sequence and possibly p38 MAPK activation and focal adhesion disassembly. Journal of Biological Chemistry 2003, 278(33):30516-30524.
79. Tawil B. An Introduction to Biomaterials. Fibrin and its applications, Review article 2005, 105-120. CRC Taylor &Francis, Boca Raton, FL, Chapter 7. S.A. Guelcher, J.O. Hollinger (Eds.).
80. Tuan T.L., Song A., Chang S., Younai S., Nimni M.E. In vitro fibroplasia: matrix contraction, cell growth, and collagen production of fibroblasts cultured in fibrin gels. Experimental Cell Research 1996, 223:127-134.
81. Tuan T.L., Zhu J.Y., Sun B., Nichter L.S., Nimni M.E., Laug W.E. Elevated levels of plasminogen activator inhibitor-1 may account for the altered fibrinolysis by keloid fibroblasts. J Invest Dermatol 1996, 106:1007-1011.
82. Vailhe B., Leconte M., Wiernsperger N., Tranqui L. The formation of tubular structures by endothelial cells is under the control of fibrinolysis and mechanical factors. Angiogenesis 1998, 2(4):331-344.
83. Van Griensven M., Zeichen J., Pape H.C., Lehmann U., Bosch U., Seekamp A.A. Modified method to culture human osteoblasts using Tissuecol® to improve bone sample adhesion and cellular outgrowth. Cells Tissues Organs 2000, 166:72-76.
84. Vanscheidt W., Ukat A., Horak V., Bruning H., Hunyadi J., Pavlicek R., Emter M., Hartmann A., Bende J., Zwingers Th, Ermuth T., Eberhardt R. Treatment of recalcitrant venous leg ulcers with autologous keratinocytes in fibrin sealant: A multinational randomized controlled clinical trial. Wound Repair and Regeneration 2007, 15:308-315.
85. Wechselberger G., Schoeller T., Stenzl A., Ninkovic M., Lille S., Russell R.C. Fibrin glue as a delivery vehicle for autologous urothelial cell transplantation onto a prefabricated pouch. The Journal of Urology 1998, 160:583-586.
86. Werner S., Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003, 83:835-870.
87. Wong C., Inman E., Spaethe R., Helgerson S. Fibrin-based biomaterials to deliver human growth factors. Thromb Haemos 2003, 89:573-582.
88. Yang Y.I., Seol D.L., Kim H.I., Cho M.H., Lee S.J. Composite fibrin and collagen scaffold to enhance tissue regeneration and angiogenesis. Current Applied Physics 2007, 7(1):e103-e107.
89. Ye O., ZüNd G., Benedikt P., Jockenhoevel S., Hoerstrup S.P., Sakyama S., Hubbell J.A., Turina M. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur J Cardiothorac Surg 2000, 17:587-591.
90. Young H., Wu B., Tawil B. Mechanical Characteristics of Fibrin and Collagen Scaffolds Impeded with Cells 2007, TERMIS, Toronto, Canada.
91. Yucel E.A., Oral O., Olgac V., Oral C.K. Effects of fibrin glue on wound healing in oral cavity. J Dent 2003, 31(8):569-575.
92. Zhang G., Wang X., Wang Z., Zhang J., Suggs L. A PEGylated fibrin patch for mesenchymal stem cell delivery. Tissue Engineering 2006, 12(1):9-19.